Cost Effectiveness [qnco]
ACE Inhibitors [phsu]
Patients [podg]
arterial hypertension [dsyn]
coronary heart disease [dsyn]
Cost Effectiveness [qnco]
ACE Inhibitors [phsu]
Patients [podg]
arterial hypertension [dsyn]
coronary heart disease [dsyn]
Guide [prog]
Appropriate [qlco]
Medication [phsu]
Process [bpoc]
Material [sbst]
Methods [inpr]
Study [mnob]
included [ftcn]
Patients [podg]
Receive [qlco]
Standard [qlco]
combined treatment [topp]
Pharmaceutical [bodm]
Plus [qlco]
Perindopril [orch, phsu]
moexipril [orch, phsu]
Fosinopril [opco, phsu]
N NOS [aapp, imft]
Group [idcn]
Patients [podg]
Administered [ftcn]
Ramipril [orch, phsu]
Effectiveness [qlco]
Fosinopril [opco, phsu]
moexipril [orch, phsu]
Perindopril [orch, phsu]
Ramipril [orch, phsu]
Group [idcn]
Blood Pressure [orgf]
reduction [npop]
Sustained [ftcn]
Ramipril [orch, phsu]
therapy [ftcn]
ACE Inhibitors [phsu]
Well [qlco]
Maximal [qlco]
Cost Effectiveness [qnco]
Minimal [qlco]
Cost [qnco]
Observed [ftcn]
Ramipril [orch, phsu]
Cost Effectiveness [qnco]
Various [irda]
Medications [phsu]
Pharmacological [bmod]
Group [idcn]
Pharmaceutical [bodm]
therapy [ftcn]
standards [inpr]
Guide [prog]
Medication [phsu]
Process [bpoc]
Patients [podg]
